January 5, 2017 / 12:53 PM / a year ago

Allergan expects mid-single digit 2017 revenue growth

Jan 5 (Reuters) - Allergan Plc said on Thursday it expects mid-single digit net revenue growth in 2017, helped by new launches and higher sales of key products.

Allergan, which will report its fourth-quarter results in February, also said it expects to achieve double-digit adjusted earnings growth in 2017.

The Dublin, Ireland-based company had said in November it expects 2016 adjusted net revenue from continuing operations to be $14.45 billion-$14.65 billion.

Allergan’s shares closed at $215.56 on Wednesday. The company’s shares had fallen 36 percent last year. (Reporting by Ankur Banerjee in Bengaluru; Editing by Shounak Dasgupta)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below